Novagen Healthcare

What Novagen Healthcare does

Novagen Healthcare Private Limited is an Indian pharmaceutical manufacturer headquartered in Vadodara, Gujarat, that researches, manufactures, and exports generic pharmaceutical formulations across 18+ therapeutic categories including NSAIDs, antibiotics (fluoroquinolones and macrolides), cardiovascular, antidiabetic, CNS, antimalarials, and gastrointestinal products. The company's manufacturing facility is designed per cGMP and US FDA guidelines, equipped with advanced automation including Automatic Granulation, Compression machines with Automatic Weigh Control (AMC), clean room technology using HEPA and ULPA filters, and real-time laboratory management software, supporting annual capacity of 3 billion tablets, 1 billion capsules, 50 million syrups, and 5 million sachets.

The business operates two interlocking revenue streams: direct sales of branded generic formulations and a contract manufacturing service line offering end-to-end capabilities from pre-formulation development and stability studies through pre-clinical/clinical trials, registration batches, and full-scale commercial production. Pricing is quote-driven and contract-based, with the company targeting enterprise pharmaceutical buyers seeking outsourced manufacturing and emerging market distributors. The company holds 500+ product registrations globally with WHO cGMP, Schedule M, ISO:14000, and country-specific regulatory approvals (PPB-Kenya, DPM-DRC, DPML-Ivory Coast, DPM-Republic of Congo), and exports regularly to Myanmar, Georgia, Papua New Guinea, Nigeria, DR Congo, Sri Lanka, Kenya, and Vietnam.

A dedicated R&D facility staffed by 15+ scientists focuses on novel drug delivery systems (mouth dissolving tablets, drug layering, modified release formulations, and taste masking) to optimize drug solubility, bioavailability, and stability. The company is privately held with no disclosed institutional investors or venture capital backing, operates from 11-50 employees, and maintains an international office in Mumbai to coordinate export operations. No financial performance data, founding date, or management team details are publicly disclosed in the source material, representing a material information gap for prospective investors.

Name

Novagen Healthcare

Legal name

Novagen Healthcare Private Limited

Website

https://novagenhealthcare.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Novagen Healthcare is an Indian pharmaceutical manufacturer in Vadodara that produces generic formulations across multiple therapeutic categories and provides contract manufacturing services, exporting to eight emerging markets under WHO cGMP certification.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Pharmaceutical contract manufacturing
• Generic drug manufacturing
• Formulation development services
• Pharmaceutical export services
• Novel drug delivery systems

Headquarters

HQ city

Vadodara

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Provides end-to-end contract manufacturing services including drug development, manufacturing, regulatory compliance, and supply chain solutions. Services include pre-formulation development, stability studies, method development, pre-clinical and clinical trials, registration batches, and commercial production. Revenue generated through manufacturing fees and product supply agreements with pharmaceutical companies.
2. Pharmaceutical Product Sales: Manufacturing and sale of generic pharmaceutical products across multiple therapeutic categories including NSAIDs, antibiotics, cardiovascular, antidiabetic, CNS, and other therapeutic areas. Products include tablets, capsules, syrups, suspensions, injectables, and sachets. Revenue generated through product sales to distributors and export markets.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Novagen Healthcare researches, develops, manufactures, and exports generic pharmaceutical finished dosage products across a wide range of therapeutic categories including anti-inflammatory/NSAIDs, antibiotics (fluoroquinolones, macrolides), cardiovascular, antidiabetic, CNS, antihistamines, antifungal/antihelmintic, antimalarial, gastrointestinal (antiemetic, antacid, PPI), nutritional, and respiratory drugs. The company also provides end-to-end contract manufacturing services for pharmaceutical partners and supports novel drug delivery system development including mouth-dissolving tablets, modified release formulations, and taste masking technologies.

Product overview

Novagen Healthcare is a pharmaceutical company offering a diverse portfolio of generic drug formulations across multiple therapeutic categories, including Anti-inflammatory/NSAIDs, Antibiotics (Fluoroquinolones, Macrolides), Cardiovascular, Antidiabetic, CNS/Neurological, Antihistamines, Antifungal, Antimalarial, and Gastrointestinal products. The company manufactures various dosage forms including Tablets, Capsules, Syrups, Suspensions, Sachets, and Injectables. Beyond product manufacturing, Novagen provides Contract Manufacturing Services for drug development through commercial production, and Research and Development Services specializing in formulations, process chemistry, and novel drug delivery systems. The company also offers Quality Assurance Services with analytical method development and stability studies.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Manufacturing Services End-to-end contract manufacturing service for pharmaceutical partners, covering formulation development, manufacturing, quality assurance, and packaging of generic finished dosage forms in a WHO cGMP-compliant facility. Targeted at pharmaceutical companies seeking outsourced manufacturing capacity.
• Research and Development Services Formulation and development services conducted at the in-house R&D facility, supporting oral solid dosages, liquid orals, and novel drug delivery systems including mouth-dissolving tablets, drug layering, modified release formulations, and taste masking. Offered to internal product teams and contract manufacturing clients.
• Quality Assurance Services Quality assurance services covering the qualified quality unit, validation processes, clean room operations, and adherence to WHO cGMP standards across manufacturing activities. Supports both in-house product release and contract manufacturing clients.
• Anti-inflammatory / NSAIDs / Narcotic Analgesic Products Generic anti-inflammatory, NSAID, and narcotic analgesic formulations in finished dosage forms such as tablets and capsules, including combinations such as Aceclofenac + Paracetamol and Aceclofenac + Serratiopeptidase. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Fluoroquinolone Antibiotic Products Generic fluoroquinolone antibiotic formulations in finished dosage forms including tablets and dry syrups, covering actives such as Ciprofloxacin, Ofloxacin, and Levofloxacin in single and combination forms. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Macrolide Antibiotic Products Generic macrolide antibiotic formulations in finished dosage forms including tablets, capsules, and dry syrups, covering Azithromycin, Clarithromycin, and Roxithromycin in single and combination forms. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Antidiarrhoeal Products Generic antidiarrhoeal formulations in finished dosage forms including capsules, tablets, and dry syrups, covering combinations of Loperamide, Ofloxacin, Ornidazole, and related actives. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Laxative Products Generic laxative formulations in finished dosage forms including sodium picosulfate-based oral solutions and combinations. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Cardiovascular Products Generic cardiovascular formulations in finished dosage forms covering Atorvastatin, Amlodipine, Telmisartan, and related actives in single and combination forms. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Antidiabetic Products Generic antidiabetic formulations in finished dosage forms covering Glimepiride, Metformin, Pioglitazone, Voglibose, and related actives in single and combination forms. Targeted at pharmaceutical distributors and contract manufacturing clients.
• CNS / Anxiolytic / Antidepressant Products Generic CNS, anxiolytic, and antidepressant formulations in finished dosage forms covering Alprazolam, Sertraline, Escitalopram, and related actives in single and combination forms. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Antihistamine Products Generic antihistamine formulations in finished dosage forms covering Cetirizine, Levocetirizine, and related actives in single and combination forms. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Antifungal and Antihelmintic Products Generic antifungal and antihelmintic formulations in finished dosage forms covering Fluconazole, Albendazole, Ivermectin, and related actives in single and combination forms. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Antimalarial Products Generic antimalarial formulations in finished dosage forms covering Artesunate, Alpha-Beta Arteether, and related actives in single and combination forms. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Antiemetic Products Generic antiemetic formulations in finished dosage forms covering Ondansetron in tablet, syrup, and injection forms. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Antacid and Gastrointestinal Products Generic antacid and gastrointestinal formulations in finished dosage forms covering Pantoprazole, Domperidone, and related combinations such as Pantoprazole + Domperidone and Ranitidine combinations. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Iron Preparation Products Generic iron preparation formulations in finished dosage forms covering Ferrous Ascorbate, Folic Acid, Zinc, and Cyanocobalamin combinations in capsules and syrups. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Vitamin Supplement Products Generic vitamin supplement formulations in finished dosage forms, including Vitamin B12 preparations and multivitamin combinations covering Methylcobalamin, Pyridoxine, Folic Acid, and Niacinamide. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Anticold, Flu and Cough Preparations Generic anticold, flu, and cough formulations in finished dosage forms covering Paracetamol, Phenylephrine, Chlorpheniramine, Dextromethorphan, and Bromhexine combinations in tablets, capsules, and syrups. Targeted at pharmaceutical distributors and contract manufacturing clients.
• Proton Pump Inhibitor (PPI) Products Generic proton pump inhibitor formulations in finished dosage forms covering Esomeprazole, Rabeprazole, and Pantoprazole in capsules and tablets. Targeted at pharmaceutical distributors and contract manufacturing clients.

Quantifiable outcome

• More than 500 products registered across the globe
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Contract Manufacturing PartnerscoreChannel Partner/ Reseller/ DistributorCompanies can outsource their manufacturing requirement to Novagen and focus their energy on marketing and development of scalability to expand and operate. Novagen provides comprehensive services from drug development and manufacturing through regulatory compliance, supply chain solutions, and business development support.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Sun Pharmaceutical Industries: Largest Indian specialty generic manufacturer with global operations. Comparable therapeutic areas and emerging-market presence, but at significantly larger scale with broader portfolio including specialty and branded segments.
• Dr. Reddy's Laboratories: Major Indian generic and specialty pharmaceutical company with global footprint including emerging markets. Comparable product categories and export markets, but materially larger and more diversified than Novagen.
• Zydus Lifesciences (Cadila Healthcare): Indian pharmaceutical company with strong generics, APIs, and biosimilars portfolio. Comparable in therapeutic breadth and emerging-market exports, though substantially larger and more diversified.

Direct peers

• Alkem Laboratories: Mid-size Indian generic manufacturer with multi-therapy portfolio and significant domestic plus international business. Comparable to Novagen in scale bracket, therapeutic mix (antibiotics, NSAIDs, CNS, GI), and contract manufacturing capabilities.
• Aurobindo Pharma: Large Indian generic pharmaceutical manufacturer with significant export presence across emerging markets and a broad therapeutic portfolio. Directly comparable to Novagen in product categories, business model, and export-led GTM, though at materially larger scale.
• Mankind Pharma: Indian pharmaceutical company with strong generic portfolio across antibiotics, cardiovascular, GI, and CNS. Comparable to Novagen in therapeutic categories and emerging-market orientation, though with larger domestic franchise.
• Ipca Laboratories: Indian generic manufacturer with strong API and finished dosage form presence, including anti-malarials and anti-infectives relevant to African markets. Comparable therapeutic mix and export-led model to Novagen.
• Macleods Pharmaceuticals: Privately held Indian generic manufacturer with broad therapeutic portfolio and significant emerging-market exports. Closest direct comparable to Novagen in size, ownership structure, product breadth, and export-led go-to-market.
• Cipla: Indian generic pharmaceutical manufacturer with strong presence in Africa, South Asia, and other emerging markets. Comparable to Novagen in therapeutic breadth and emerging-market focus, including branded generics across respiratory, CNS, and cardiovascular.

Emerging players

• Piramal Pharma: Indian pharmaceutical and contract development services company with CDMO operations. Comparable to Novagen's contract manufacturing motion and part of comparable generic portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novagen Healthcare